Skip to main content

and
  1. Article

    Open Access

    Recommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology

    Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extragl...

    Alisson Pugliesi, Danielle Christinne Soares do Egypto in Advances in Rheumatology (2024)

  2. No Access

    Article

    Assessment of hydroxychloroquine blood levels in Sjögren’s disease patients: drug adherence and clinical associations

    Hydroxychloroquine (HCQ) has been used to treat Sjögren’s disease (SjD) patients. However, there are no studies evaluating drug adherence through HCQ blood levels, pharmacy refill (PR) and medication adherence...

    Sandra Gofinet Pasoto, Lorena Elizabeth Betancourt Villamarín in Rheumatology International (2024)

  3. No Access

    Article

    Effects of a lifestyle intervention on cardiovascular risk factors in systemic lupus erythematosus patients: The study “Living well with lupus”

    The aim of the present study was to investigate the effects of a lifestyle intervention on cardiometabolic risk factors in patients with systemic lupus erythematosus with a high cardiovascular risk profile.

    Sofia Mendes Sieczkowska, Bruna Caruso Mazzolani in Clinical Rheumatology (2024)

  4. No Access

    Article

    A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study “Living Well with Lupus”

    There is a paucity of studies assessing multidisciplinary interventions focused on tackling physical inactivity/sedentary behavior and poor dietary habits in SLE. The Living well with Lupus (LWWL) is a randomi...

    Sofia Mendes Sieczkowska, Fabiana Infante Smaira in Rheumatology International (2023)

  5. No Access

    Article

    Shrinking lung syndrome in primary Sjögren’s syndrome: a case-based review

    Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease that affects exocrine glands, mainly the salivary and lacrimal glands, leading to the development of sicca symptoms. Patients with pSS may also...

    Jobson Lopes de Oliveira, Rafael Alves Cordeiro in Rheumatology International (2023)

  6. No Access

    Article

    Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjögren syndrome

    Influenza A (H3N2) virus is the major cause of morbidity/mortality due to seasonal influenza over 50 years. Data about the safety/immunogenicity of influenza A/Singapore (H3N2) vaccine are scarce in primary Sj...

    Sandra Gofinet Pasoto, Eduardo Ferreira Borba in Clinical Rheumatology (2023)

  7. Article

    Open Access

    Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition

    Data on post-acute COVID-19 in autoimmune rheumatic diseases (ARD) are scarce, focusing on a single disease, with variable definitions of this condition and time of vaccination. The aim of this study was to ev...

    Clovis Artur Silva, Leonard de Vinci Kanda Kupa in Advances in Rheumatology (2023)

  8. Article

    Open Access

    Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)

    Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varyin...

    Virginia Fernandes Moça Trevisani, Aysa César Pinheiro in Advances in Rheumatology (2022)

  9. Article

    Open Access

    VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells

    The VI Brazilian Consensus on Autoantibodies against HEp-2 cells for determination of autoantibodies against cellular constituents on HEp-2 cells was held on September, 2019, in Fortaleza (CE, Brazil). The gui...

    Wilson de Melo Cruvinel, Luis Eduardo Coelho Andrade in Advances in Rheumatology (2022)

  10. Article

    Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity

    There is no study specifically focused on SARS-CoV-2 vaccine in primary Sjögren’s syndrome (pSS).

    Sandra Gofinet Pasoto, Ari Stiel Radu Halpern in Clinical Rheumatology (2022)

  11. Article

    Open Access

    Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal)

    Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varyin...

    Virginia Fernandes Moça Trevisani, Alisson Pugliesi in Advances in Rheumatology (2022)

  12. Article

    Open Access

    2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren’s syndrome

    Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs. Women with SS often experience gynecological symptoms due to the disease and ...

    Fabiola Reis Oliveira, Valeria Valim, Sandra Gofinet Pasoto in Advances in Rheumatology (2021)

  13. No Access

    Article

    Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching

    To assess the longitudinal production of anti-adalimumab antibody (AAA) and baseline risk factors for this antibody development in juvenile idiopathic arthritis (JIA) patients initiating adalimumab (ADA).

    Juliana Barbosa Brunelli, Clovis Almeida Silva in Clinical Rheumatology (2020)

  14. Article

    Open Access

    Correction to: V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells

    After publication of the original article [1], we were notified that there is a mistake in Fig. 2.

    Wilson de Melo Cruvinel, Luis Eduardo Coelho Andrade in Advances in Rheumatology (2020)

  15. Article

    Open Access

    Recommendations from the Brazilian society of rheumatology for the diagnosis of Sjögren’s syndrome (Part I): glandular manifestations (systematic review)

    Primary Sjögren’s syndrome (pSS) is a systemic immune-mediated disease whose main characteristic is exocrine gland inflammation and, subsequent reduction in tear and saliva production. A delayed diagnosis is c...

    Virginia Fernandes Moça Trevisani, Sandra Gofinet Pasoto in Advances in Rheumatology (2019)

  16. Article

    Open Access

    Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity

    Type V collagen (Col V) has the potential to become an autoantigen and has been associated with the pathogenesis of systemic sclerosis (SSc). We characterized serological, functional, and histopathological fea...

    Walcy Rosolia Teodoro, Zelita Aparecida de Jesus Queiroz in Arthritis Research & Therapy (2019)

  17. Article

    Open Access

    V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells

    The V Brazilian Consensus for determination of autoantibodies against cellular constituents on HEp-2 cells, held in Brasilia (DF, Brazil) on August 27, 2016, discussed the harmonization between the Brazilian C...

    Wilson de Melo Cruvinel, Luis Eduardo Coelho Andrade in Advances in Rheumatology (2019)

  18. No Access

    Article

    Metabolic syndrome in Sjögren’s syndrome patients: a relevant concern for clinical monitoring

    Metabolic syndrome (MetS) has been described in autoimmune diseases. However, there are scarce data about MetS and adipocytokine profile in primary Sjögren’s syndrome (pSS). Seventy-one female pSS patients (Am...

    Kristopherson Lustosa Augusto, Eloisa Bonfa in Clinical Rheumatology (2016)

  19. No Access

    Article

    EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement?

    Antibody to Epstein–Barr virus (EBV) early antigen diffuse (anti-EA-D) is associated with viral replication. However, their possible associations with clinical/therapeutic features in primary Sjögren’s syndrom...

    Sandra Gofinet Pasoto, Renato Romera Natalino in Rheumatology International (2013)

  20. No Access

    Article

    Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome

    Antiphospholipid antibodies (aPL) and antiphospholipid syndrome (APS) have been described in primary Sjögren’s syndrome (pSS) with controversial findings regarding aPL prevalence and their association with thr...

    Sandra Gofinet Pasoto, Henrique Pires Chakkour in Clinical Rheumatology (2012)